(R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate

We are (R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate CAS:143900-43-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate
CAS.NO:143900-43-0
Synonyms:(R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate
(R)-1-Boc-3-Hydroxypiperidine
R-1-Boc-3-hydroxypiperidine
tert-butyl (3R)-3-hydroxypiperidine-1-carboxylate
(R)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine
(R)-1-Boc-3-piperidinol
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 292.3±33.0 °C at 760 mmHg
Melting Point 43-50ºC
Molecular Formula C10H19NO3
Molecular Weight 201.263
Flash Point 130.6±25.4 °C
 
Specification:
Appearance:White solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ibrutinib.

(R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate


Related News: China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.864377-33-3 The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.disodio, 1,7-dihidroxi-4-nitroheptano-1,7-disulfonato CAS:900186-74-5 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.5-Chloro-2-fluorotoluene According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.

Related Products
Product Name
H-HIS-GLY-GLY-OH View Details
Dibenzothiophene-2-Boronic Acid View Details
3,5-Diaminobenzotrifluoride View Details
4-Amino-L-phenyl-N-phthalylalanine ethyl ester manufacturer tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate manufacturer 2-(4-nitrophenyl)ethanamine,hydrochloride manufacturer (R)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate manufacturer BOC-PHE-OBZL manufacturer